VR Effects After Hip Replacement Surgery Pain

NCT07689461 | Recruiting DMC

• 1 other identifier: VR-THA-2026
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Total Hip Arthroplasty (THA), a procedure performed to enhance the quality of life, is accompanied by postoperative challenges such as pain and anxiety that adversely affect patient comfort. Inadequate management of these complications can prolong the length of hospital stay, delay recovery, lead to functional impairments, and elevate the risk of chronic pain development. Conventional pharmacological interventions employed for management are limited due to their potential for adverse effects and dependency. Virtual reality (VR) is a non-pharmacological distraction technique utilized in the healthcare sector, leveraging advanced technology to maximize patient comfort by alleviating pain and minimizing anxiety. A review of the literature reveals that while the use of VR has positive effects on pain and anxiety, there is a notable scarcity of high-quality randomized controlled trials concurrently evaluating its impact on pain, anxiety, and comfort levels in postoperative orthopedic procedures such as THA. In this randomized controlled trial, participants in the control group will receive standard care, whereas those in the experimental group will receive a 30-minute VR intervention-offering three distinct options-in addition to standard care during the acute phase of the first 48 hours. Postoperative assessments will be conducted using the Visual Analogue Scale (VAS) for pain intensity, the State Anxiety Inventory for anxiety levels, and the Perianesthesia Comfort Scale for comfort levels. By evaluating the potential of VR as a non-pharmacological adjuvant in post-THA care, the findings of this study will provide significant contributions to evidence-based nursing practices aimed at developing multimodal pain management strategies, reducing opioid consumption, and enhancing patient satisfaction.

Conditions

Comfort; Hip Arthropathy; Anxiety; Pain, Postoperative; Virtual Reality

Keywords

Virtual Reality; Total Hip Arthroplasty; Postoperative Pain; Anxiety; Comfort Level

Outcome Measures

Primary Outcomes (3)

• Evaluation of Pain in Patients After Total Hip Arthroplasty Surgery

  The Visual Analog Scale (VAS) was used to measure pain intensity; it is a simple, unidimensional measure. It was developed by Price et al. in 1983 to assess perceived pain. Compared to the VAS scale, which is known to be more sensitive in the assessment and characterization of acute pain, "no pain" is rated as 0 points and "most severe pain" as 10 points. On this scale, an increase in score indicates an increase in pain. Pain is also categorized as mild (\<3), moderate (3-6), and severe (\>6).

  The first 24 hours after surgery, 25-48 hours after surgery

• Evaluation of Anxiety in Patients After Total Hip Arthroplasty Surgery

  The Spielberger State-Trait Anxiety Inventory was used to assess patients' anxiety levels. The original scale was developed in 1970 by Spielberger and his team and adapted to the Turkish language and culture by Öner and Le Compte. Scale items are answered on a four-point Likert-type scale. For the state anxiety scale, the response options are "not at all," "a little," "a lot," and "completely," while for the trait anxiety scale, they are "never," "sometimes," "most of the time," and "almost always." Higher scores on the scale indicate higher levels of anxiety, while lower scores indicate lower levels of anxiety. According to the score ranges established by Spielberger and colleagues, a score of 0-19 indicates no anxiety, 20-39 indicates mild anxiety, 40-59 indicates moderate anxiety, and 60-79 indicates severe anxiety.

  The first 24 hours after surgery, 25-48 hours after surgery

• Evaluation of Comfort Levels in Patients After Total Hip Arthroplasty Surgery

  The comfort levels of postoperative patients were assessed using the Perianesthesia Comfort Scale. The scale was developed by Kolcaba in 1990 and adapted into Turkish by Üstündağ and Aslan (2010). The Perianesthesia Comfort Scale (PCS) is a self-report assessment tool designed to measure individuals' comfort levels during the perianesthesia period. The scale consists of a total of 24 items and uses a six-point Likert-type scale. Participants respond to each item with scores ranging from "strongly disagree (1)" to "strongly agree (6)." The total score that can be obtained from the scale ranges from 24 to 144. The total score is divided by the number of items to calculate the mean score, which is expressed as a value between 1 and 6. A low mean score indicates a low level of comfort, while a high mean score indicates a high level of comfort.

  The first 24 hours after surgery, 25-48 hours after surgery

Study Arms (2)

Experimental Group

EXPERIMENTAL

Participants in the experimental group will undergo a virtual reality headset intervention. This intervention will be administered to patients in the clinic during the acute phase-the first 48 hours following total hip replacement surgery. The scales used in the study will be administered twice: once before and once after the intervention.

Behavioral: cognitive intervention

Control Group

NO INTERVENTION

Participants in the control group will receive standard care. The intervention will be administered to patients who are in the clinic during the acute phase-the first 48 hours-following total hip replacement surgery. The scales used in the study will be administered twice: once before and once after the intervention.

Interventions

cognitive intervention BEHAVIORAL

The patient undergoing the virtual reality session will lie in a supine position, supported and comfortable, with the head elevated at an angle of 30˚-45˚. The content will feature nature sounds and soothing background music; three different segments will be programmed: a forest or beach landscape, an underwater scene, and an outdoor excursion. Each option consists of 30 minutes of footage. The patient will select their preferred footage from these options, and after the sound settings are adjusted to a level the patient finds comfortable and non-disturbing, the session will begin and last for 30 minutes. Following the session, data will be collected in a face-to-face setting.

Experimental Group

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients scheduled for elective surgery who agree to participate in the study,
• Individuals 18 years of age or older,
• Those with adequate cognitive function,
• Those who have not previously undergone total hip replacement surgery,
• Those who volunteer to participate in the study and sign the informed consent form,
• Patients with a pain score (on a scale of 1 to 10) of 4 or higher were included in the study.

You may not qualify if:

• Individuals under the age of 18,
• Those previously diagnosed with a chronic pain syndrome (other than hip osteoarthritis),
• Individuals with impaired cognitive function (severe psychiatric disorders),
• Individuals who have previously undergone total hip replacement surgery,
• Individuals with severe hearing or visual impairments,
• Individuals with a history of opioid dependence,
• Patients with a pain score (on a scale of 1 to 10) of 4 or lower were excluded from the study.

Sponsors & Collaborators

• Adiyaman University: lead

Study Sites (1)

Malatya Turgut Özal University

Malatya, 44900, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders; Pain, Postoperative

Condition Hierarchy (Ancestors)

Mental Disorders; Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms

Study Officials

• OĞUZHAN ÇAĞLAR, MSc Std

  Adiyaman University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

OĞUZHAN ÇAĞLAR, MSc Std

CONTACT

5423455495; ocaglar@adiyaman.edu.tr

BİLSEV DEMİR, Assoc. Prof.

CONTACT

5364083761; bilsev.demir@ozal.edu.tr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Model Details: Randomized Controlled Research

Study Record Dates

• First Submitted: July 1, 2026
• First Posted: July 8, 2026
• Study Start: October 21, 2025
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2026
• Last Updated: July 8, 2026

Record last verified: 2026-07

Locations

TU (1)